{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:23:09Z","timestamp":1780089789127,"version":"3.54.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>\n                    <jats:sup>68<\/jats:sup>\n                    Ga-FAPI PET demonstrates superior detection of primary lesions in cholangiocarcinoma compared with\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET, making it commonly used in the diagnosis of biliary diseases. Herein, we reported the\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG and\n                    <jats:sup>68<\/jats:sup>\n                    Ga-FAPI-04 PET\/MR findings in a 38-year-old man experiencing acute cholangitis. The lesions exhibited negative\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG uptake but intense\n                    <jats:sup>68<\/jats:sup>\n                    Ga-FAPI-04 uptake on PET\/MR.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006225","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T17:01:08Z","timestamp":1765904468000},"page":"188-190","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Negative 18F-FDG and Positive 68Ga-FAPI-04 Findings in a Patient With Acute Cholangitis"],"prefix":"10.1097","volume":"51","author":[{"given":"Na","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"R1-20260107","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00535-013-0790-5","article-title":"Clinical application of 18F-fluorodeoxyglucose positron emission tomography for assessment and evaluation after therapy for malignant hepatic tumor","volume":"49","author":"Tsurusaki","year":"2014","journal-title":"J Gastroenterol"},{"key":"R2-20260107","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00259-003-1297-8","article-title":"Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma","volume":"30","author":"Kim","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R3-20260107","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2967\/jnumed.122.265215","article-title":"Superior tumor detection for (68)Ga-FAPI-46 versus (18)F-FDG PET\/CT and conventional CT in patients with cholangiocarcinoma","volume":"64","author":"Pabst","year":"2023","journal-title":"J Nucl Med"},{"key":"R4-20260107","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1007\/s00259-023-06188-2","article-title":"Correction to: clinical prospective study of gallium 68 (68Ga)-labeled fibroblast\u2011activation protein inhibitor PET\/CT in the diagnosis of biliary tract carcinoma","volume":"50","author":"Jinghua","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-20260107","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1148\/radiol.213118","article-title":"Prospective comparison of (68)Ga-FAPI versus (18)F-FDG PET\/CT for tumor staging in biliary tract cancers","volume":"304","author":"Lan","year":"2022","journal-title":"Radiology"},{"key":"R6-20260107","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13550-024-01145-y","article-title":"Role of [(18)F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [(18)F]FDG PET\/CT","volume":"14","author":"Liang","year":"2024","journal-title":"EJNMMI Res"},{"key":"R7-20260107","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/RLU.0000000000005504","article-title":"Negative 18 F-FDG and positive 68 Ga-FAPI-04 findings in a patient with acute exacerbation of chronic cholecystitis","volume":"50","author":"Qi","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R8-20260107","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/RLU.0000000000002914","article-title":"Intense FAPI uptake in inflammation may mask the tumor activity of pancreatic cancer in 68Ga-FAPI PET\/CT","volume":"45","author":"Luo","year":"2020","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T19:00:25Z","timestamp":1767812425000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006225","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"2025-08-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}